Embed

Academic

Authors

Lee Lee Chan

Lee Lee Chan,Cardiology,Family Medicine,Pathology

Edit

Lee Lee Chan

Publications: 7 | Citations: 34

Fields: Cardiology, Family Medicine, Pathology

Collaborated with 47 co-authors from 2005 to 2010 | Cited by 90 authors

Cumulative Annual

Sort by:

Publications (7)

BibTeX | RIS | RefWorks Download

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias (Citations: 11)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=33474629&selfId1=56830072&selfId2=0&maxNumber=12&query=

Journal: Haematologica-the Hematology Journal , vol. 95, no. 4, pp. 557-566, 2010

Efficacy of deferasirox in reducing and preventing cardiac iron overload in -thalassemia (Citations: 10)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=29976119&selfId1=56830072&selfId2=0&maxNumber=12&query=

Journal: Blood , vol. 115, no. 12, pp. 2364-2371, 2010

IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®) IN REDUCING CARDIAC SIDEROSIS IN β-THALASSEMIA PATIENTS: 2YEAR RESULTS FROM THE EPIC CARDIAC SUBSTUDY

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=33207509&selfId1=56830072&selfId2=0&maxNumber=12&query=

Journal: Journal of The American College of Cardiology - J AMER COLL CARDIOL , vol. 55, no. 10, pp. A83.E785-A83.E785, 2010

Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias (Citations: 9)

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=13757003&selfId1=56830072&selfId2=0&maxNumber=12&query=

Published in 2009.

Characterisation and confirmation of rare beta‐thalassaemia mutations in the Malay, Chinese and Indian ethnic groups in Malaysia (Citations: 4)

, , , , ,

Journal: Pathology , vol. 38, no. 5, pp. 437-441, 2006

Sort by:

Citations (34 times by 26 publications)

The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate (Citations: 2)

, ,

Journal: Current Hematologic Malignancy Reports , vol. 6, no. 2, pp. 136-144, 2011

Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=47606480&selfId1=56830072&selfId2=0&maxNumber=12&query=

Journal: International Journal of Hematology - INT J HEMATOL , vol. 93, no. 3, pp. 319-328, 2011

Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia

, , , , , , ,

Journal: Annals of Hematology - ANN HEMATOL , vol. 90, no. 1, pp. 11-15, 2011

A Case of Well-Tolerated and Safe Deferasirox Administration during the First Trimester of a Spontaneous Pregnancy in an Advanced Maternal Age Thalassemic Patient

, , , , ,

Journal: Acta Haematologica - ACTA HAEMATOL , vol. 125, pp. 222-224, 2011

Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population

, ,

Journal: BMC Public Health , vol. 11, no. 1, pp. 1-9, 2011

Comments

Co-authors (47)

Journals (6)

Keywords (17)

Lee Lee Chan,Cardiology,Family Medicine,Pathology

Publications (7)

BibTeX | RIS | RefWorks Download

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias (Citations: 11)

Efficacy of deferasirox in reducing and preventing cardiac iron overload in -thalassemia (Citations: 10)

IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®) IN REDUCING CARDIAC SIDEROSIS IN β-THALASSEMIA PATIENTS: 2YEAR RESULTS FROM THE EPIC CARDIAC SUBSTUDY

Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias (Citations: 9)

Characterisation and confirmation of rare beta‐thalassaemia mutations in the Malay, Chinese and Indian ethnic groups in Malaysia (Citations: 4)

Citations (34 times by 26 publications)

The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate (Citations: 2)

Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox

Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia

A Case of Well-Tolerated and Safe Deferasirox Administration during the First Trimester of a Spontaneous Pregnancy in an Advanced Maternal Age Thalassemic Patient

Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population


	View FAQ about top research areas and Fields of study

Lee Lee Chan,Cardiology,Family Medicine,Pathology

Publications (7) BibTeX | RIS | RefWorks Download

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias (Citations: 11)

Efficacy of deferasirox in reducing and preventing cardiac iron overload in -thalassemia (Citations: 10)

Tailoring iron chelation by iron intake and serum ferritin: prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias (Citations: 9)

Characterisation and confirmation of rare beta‐thalassaemia mutations in the Malay, Chinese and Indian ethnic groups in Malaysia (Citations: 4)

The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate (Citations: 2)

Publications (7)

BibTeX | RIS | RefWorks Download